Current Applications andĀ Advances in Fluorescence Guided Surgery

Faculty:
 
Costas G. Hadjipanayis, MD, PhD, FAANS

Professor and Chair
Dept. of Neurosurgery
Mount Sinai Beth Israel

Director of Neurosurgical Oncology
Mount Sinai Health System

Director, Mount Sinai Brain Tumor Nanotechnology Laboratory
Tisch Cancer Institute at Mount Sinai
Icahn School of Medicine at Mount Sinai


Course Description:
 
Participants will be receive an overview on the concept of fluorescence-guided surgery (FGS) for the resection of brain and spinal cord tumors. Neurosurgeons will understand the current technologies available for FGS and the different tumor types that can undergo FGS. Safety, diagnostic accuracy, and Level 1 evidence in support of FGS will also be discussed.


Learning Objectives:
 
Upon completion of this activity, participants should be able to:
 
~ Define the use of FGS for brain tumors with 5-aminolevulinic acid (5-ALA) and fluorescein
~ Identify different brain and spinal cord tumor types that are amenable to FGS 
~ Distinguish the technical aspects of FGS, including the use of FGS for real-time intraoperative guidance, tumor margin visualization, and reported extents of tumor resection.
~ Explain patient safety with FGS
~ Demonstrate the difference between current and future FGS microscope technology; and
~ Summarize the current US regulatory state for FGS.
 
***This webinar does not provide CME credit.
 

Costas G. Hadjipanayis

MD, PhD, FAANS

Professor and Chair
Dept. of Neurosurgery, Mount Sinai Beth Israel


Director, Neurosurgical Oncology
Mount Sinai Health System
Icahn School of Medicine at Mount Sinai


Director, Brain Tumor Nanotechnology Laboratory
Tisch Cancer Institute

Components visible upon registration.